Sox17 regulates liver lipid metabolism and adaptation to fasting

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Rommelaere, Samuel ^a,b   Millet, Virginie ^a,b   Vu Manh, Thien Phong ^a,b   Gensollen, Thomas ^a,b   Andreoletti, Pierre ^e   Cherkaoui Malki, Mustapha ^e   Bourges, Christophe ^a,b   Escalière, Bertrand ^a,b   Du, Xin ^d   Xia, Yu ^d   Imbert, Jean ^b   Beutler, Bruce ^d   Kanai, Yoshiakira ^c   Malissen, Bernard ^a,b   Malissen, Marie ^a,b   Tailleux, Anne ^b   Staels, Bart ^b   Galland, Franck ^a,b   Naquet, Philippe ^a,b  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e Faculté des Sciences Gabriel   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; FENOFIBRATE; PANTETHEINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRANSCRIPTION FACTOR SOX17; UNCLASSIFIED DRUG; VANIN 1; AMIDASE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HIGH MOBILITY GROUP B PROTEIN; SOX17 PROTEIN, MOUSE; SOX9 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX; TRANSCRIPTION FACTOR SOX9; TRANSCRIPTOME;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME BLOOD LEVEL; FATTY ACID OXIDATION; FEMALE; GENE; GENE MUTATION; GENETIC TRANSCRIPTION; HIGH MOBILITY GROUP BOX DOMAIN; LIPID METABOLISM; LIVER METABOLISM; METABOLIC ADAPTATION; MOUSE; MOUSE MUTANT; MUTAGENESIS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; TRANSCRIPTOMICS; VNN1 GENE; ANIMAL; BLOOD; GENETICS; LIVER; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ADAPTATION, PHYSIOLOGICAL; AMIDOHYDROLASES; ANIMALS; FASTING; GPI-LINKED PROTEINS; HMGB PROTEINS; LIPID METABOLISM; LIVER; MICE; MICE, TRANSGENIC; PPAR ALPHA; SOX9 TRANSCRIPTION FACTOR; SOXF TRANSCRIPTION FACTORS; TRANSCRIPTOME;

EID: 84929051811     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104925     Document Type: Article

References (36)

1. Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK, et al. (2000) Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem 275: 28918-28928.
2. Leone TC, Weinheimer CJ, Kelly DP (1999) A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 96: 7473-7478. (Pubitemid 29299686)
3. Rakhshandehroo M, Knoch B, Muller M, Kersten S (2010) Peroxisome proliferator-activated receptor alpha target genes. PPAR research 2010.
4. Lefebvre P, Chinetti G, Fruchart JC, Staels B (2006) Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 116: 571-580. (Pubitemid 43326861)
5. Reddy JK, Hashimoto T (2001) Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr 21: 193-230. (Pubitemid 32695270)
6. Glass CK, Saijo K (2010) Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nature reviews Immunology 10: 365-376.
7. Boergesen M, Pedersen TA, Gross B, van Heeringen SJ, Hagenbeek D, et al. (2012) Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor alpha in mouse liver reveals extensive sharing of binding sites. Molecular and cellular biology 32: 852-867.
8. Dongol B, Shah Y, Kim I, Gonzalez FJ, Hunt MC (2007) The acyl-CoA thioesterase I is regulated by PPARalpha and HNF4alpha via a distal response element in the promoter. Journal of lipid research 48: 1781-1791. (Pubitemid 47311995)
9. Yao CX, Xiong CJ, Wang WP, Yang F, Zhang SF, et al. (2012) Transcription factor GATA-6 recruits PPARalpha to cooperatively activate Glut4 gene expression. J Mol Biol 415: 143-158.
10. Martinez-Jimenez CP, Kyrmizi I, Cardot P, Gonzalez FJ, Talianidis I (2010) Hepatocyte nuclear factor 4alpha coordinates a transcription factor network regulating hepatic fatty acid metabolism. Mol Cell Biol 30: 565-577.
11. Rommelaere S, Millet V, Gensollen T, Bourges C, Eeckhoute J, et al. (2013) PPARalpha regulates the production of serum Vanin-1 by liver. FEBS Lett.
12. Berruyer C, Martin FM, Castellano R, Macone A, Malergue F, et al. (2004) Vanin-12/2 mice exhibit a glutathione-mediated tissue resistance to oxidative stress. Mol Cell Biol 24: 7214-7224. (Pubitemid 39014447)
13. Berruyer C, Pouyet L, Millet V, Martin FM, LeGoffic A, et al. (2006) Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity. J Exp Med 203: 2817-2827. (Pubitemid 46026160)
14. Liang Y, Cucchetti M, Roncagalli R, Yokosuka T, Malzac A, et al. (2013) The lymphoid lineage-specific actin-uncapping protein Rltpr is essential for costimulation via CD28 and the development of regulatory T cells. Nat Immunol 14: 858-866.
15. Wilson MJ, Jeyasuria P, Parker KL, Koopman P (2005) The transcription factors steroidogenic factor-1 and SOX9 regulate expression of Vanin-1 during mouse testis development. The Journal of biological chemistry 280: 5917-5923. (Pubitemid 40280075)
16. Martin F, Malergue F, Pitari G, Philippe JM, Philips S, et al. (2001) Vanin genes are clustered (human 6q22-24 and mouse 10A2B1) and encode isoforms of pantetheinase ectoenzymes. Immunogenetics 53: 296-306. (Pubitemid 32678764)
17. Palasingam P, Jauch R, Ng CK, Kolatkar PR (2009) The structure of Sox17 bound to DNA reveals a conserved bending topology but selective protein interaction platforms. J Mol Biol 388: 619-630.
18. Pfister S, Jones VJ, Power M, Truisi GL, Khoo PL, et al. (2011) Sox17-dependent gene expression and early heart and gut development in Sox17-deficient mouse embryos. The International journal of developmental biology 55: 45-58.
19. Hosking BM, Wang SC, Downes M, Koopman P, Muscat GE (2004) The VCAM-1 gene that encodes the vascular cell adhesion molecule is a target of the Sry-related high mobility group box gene, Sox18. The Journal of biological chemistry 279: 5314-5322. (Pubitemid 38220552)
20. Schrader M, Fahimi HD (2006) Growth and division of peroxisomes. International review of cytology 255: 237-290. (Pubitemid 44914173)
21. Shimizu M, Akter MH, Emi Y, Sato R, Yamaguchi T, et al. (2006) Peroxisome proliferator-activated receptor subtypes differentially cooperate with other transcription factors in selective transactivation of the perilipin/PEX11 alpha gene pair. J Biochem 139: 563-573. (Pubitemid 43667121)
22. Gartner J, Valle D (1993) The 70 kDa peroxisomal membrane protein: an ATP-binding cassette transporter protein involved in peroxisome biogenesis. Seminars in cell biology 4: 45-52.
23. Slauter RW, Yamazaki RK (1984) Glucagon and fasting do not activate peroxisomal fatty acid beta-oxidation in rat liver. Arch Biochem Biophys 233: 197-202. (Pubitemid 14071015)
24. Hunt MC, Solaas K, Kase BF, Alexson SE (2002) Characterization of an acylcoA thioesterase that functions as a major regulator of peroxisomal lipid metabolism. J Biol Chem 277: 1128-1138. (Pubitemid 34968860)
25. Kanai-Azuma M, Kanai Y, Gad JM, Tajima Y, Taya C, et al. (2002) Depletion of definitive gut endoderm in Sox17-null mutant mice. Development 129: 2367-2379. (Pubitemid 34863845)
26. Uemura M, Ozawa A, Nagata T, Kurasawa K, Tsunekawa N, et al. (2013) Sox17 haploinsufficiency results in perinatal biliary atresia and hepatitis in C57BL/6 background mice. Development 140: 639-648.
27. Spence JR, Lange AW, Lin SC, Kaestner KH, Lowy AM, et al. (2009) Sox17 regulates organ lineage segregation of ventral foregut progenitor cells. Dev Cell 17: 62-74.
28. Matsui T, Kanai-Azuma M, Hara K, Matoba S, Hiramatsu R, et al. (2006) Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice. Journal of cell science 119: 3513-3526. (Pubitemid 44501857)
29. Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, et al. (2005) "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab 1: 309-322. (Pubitemid 43977168)
30. Zadravec D, Brolinson A, Fisher RM, Carneheim C, Csikasz RI, et al. (2010) Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 24: 4366-4377.
31. Guillou H, Zadravec D, Martin PG, Jacobsson A (2010) The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. Prog Lipid Res 49: 186-199.
32. Taschler U, Radner FP, Heier C, Schreiber R, Schweiger M, et al. (2011) Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. J Biol Chem 286: 17467-17477.
33. Zaidi N, Lupien L, Kuemmerle NB, Kinlaw WB, Swinnen JV, et al. (2013) Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids. Prog Lipid Res 52: 585-589.
34. Kovacs WJ, Shackelford JE, Tape KN, Richards MJ, Faust PL, et al. (2004) Disturbed cholesterol homeostasis in a peroxisome-deficient PEX2 knockout mouse model. Molecular and cellular biology 24: 1-13. (Pubitemid 38010030)
35. Kiefer JC (2007) Back to basics: Sox genes. Dev Dyn 236: 2356-2366.
36. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, et al. (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437: 759-763. (Pubitemid 41486547)